Form D · Biotechnology
Farapulse, Inc.
Menlo Park, CA · CIK 0001609573
Offering snapshot reported Aug 13, 2018 · SEC filing
- Reported sold
- $12M Offering amount: $12M
- Investors reported
- 32 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 31, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 13, 2018 | Initial | $11,999,993 | No comparison | 32 | SEC filing |
| Jul 11, 2017 | Initial | $5,000,000 | No comparison | 2 | SEC filing |
| Mar 3, 2016 | Initial | $14,999,173 | No comparison | 35 | SEC filing |
| Oct 13, 2015 | Amendment | $4,300,080 | $2,125,000vs Feb 23, 2015 | 34 | SEC filing |
| Feb 23, 2015 | Amendment | $2,175,080 | $500,000vs Jan 8, 2015 | 24 | SEC filing |
| Jan 8, 2015 | Amendment | $1,675,080 | $925,000vs Oct 10, 2014 | 21 | SEC filing |
| Oct 10, 2014 | Amendment | $750,080 | $350,000vs Jul 10, 2014 | 12 | SEC filing |
| Jul 10, 2014 | Amendment | $400,080 | $0vs Jun 9, 2014 | 8 | SEC filing |
| Jun 9, 2014 | Initial | $400,080 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-319020
Series A-2 Preferred Stock; Common Stock issuable upon conversion of Series A-2 Preferred Stock.
Source: Form D, filed Aug 13, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Booth | Director |
| Craig P. Colmar | Director |
| Howard Dittrich | Director |
| James Eadie | Director |
| Andrew Elbardissi | Director |
| David Jacques | Executive |
| Chris Kaster | Director |
| Christopher Kaster | Director |
| Steven Richard Mickelsen | Director, Executive, Promoter |
| John Slump | Promoter |
| Raju Viswanathan | Executive |
| Robert Weisskoff | Director |
| Allan Zingeler | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3715 Haven Avenue Suite 110
Menlo Park, CA, 94025
Menlo Park, CA, 94025